Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
Naturally Occurring Antibodies as Therapeutics for Neurologic Disease : Can Human Monoclonal IgMs Replace the Limited Resource IVIG?
Ischemic skin necrosis caused by glatiramer acetate in multiple sclerosis patients.
Vital role of specialist MS nurses recognised in proposed guideline.
Depressive Symptoms in Multiple Sclerosis from an In Vivo Study with TBSS.
Lipopolysaccharide treatment arrests the cell cycle of BV-2 microglial cells in G1 phase and protects them from UV light-induced apoptosis.
Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use.
2nd International Symposium on Gait and Balance in Multiple Sclerosis: interventions for gait and balance in MS.
Tolerogenic dendritic cells produced by Lentiviral-mediated CD40- and IL-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing Th17 cells.
Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders.
A single session of 1 mA anodal tDCS-supported motor training does not improve motor performance in patients with multiple sclerosis.
CD226 ligation protects against EAE by promoting IL-10 expression via regulation of CD4+ T cell differentiation.
ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target.
Adolescent-onset Krabbe disease with an initial diagnosis of multiple sclerosis and a novel mutation.
Blind analysis: Hide results to seek the truth.
Activity-dependent regulation of excitable axonal domains.
Cigarette smoking and the risk of multiple sclerosis: a sibling case-control study in Isfahan, Iran.
The role of cerebellar abnormalities in neuromyelitis optica - a comparison with multiple sclerosis and healthy controls.
TREM2 regulates microglial cell activation in response to demyelination in vivo.
Free radicals: properties, sources, targets, and their implication in various diseases.
Can the irradiated brain be salvaged by oligodendrocyte precursor transplantation?
"Liberation treatment" for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free.
ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis.
[Pay attention to the related advances of demyelinating diseases in the central nervous system].
Soluble CD146 in cerebrospinal fluid of active multiple sclerosis.

Pages